MIT and Toyota release innovative dataset to accelerate autonomous driving research

The following was issued as a joint release from the MIT AgeLab and Toyota Collaborative Safety Research Center. How can we train self-driving vehicles to have a deeper awareness of the world around them? Can computers learn from past experiences to recognize future patterns that can help them safely navigate new and unpredictable situations? These are some of the questions researchers from the AgeLab at the MIT Center for Transportation and Logistics and the Toyota Collaborative Safety Research Center (CSRC) are trying to answer by sharing an innovative new open dataset called DriveSeg. Through the release of DriveSeg, MIT and Toyota are working to advance research in autonomous driving systems that, much like human perception, perceive the driving environment as a continuous flow of visual information. “In sharing this dataset, we hope to encourage researchers, the industry, and other innovators to develop new insight and direction into temporal AI modeling Continue reading MIT and Toyota release innovative dataset to accelerate autonomous driving research

MIT-Takeda program launches

In February, researchers from MIT and Takeda Pharmaceuticals joined together to celebrate the official launch of the MIT-Takeda Program. The MIT-Takeda Program aims to fuel the development and application of artificial intelligence (AI) capabilities to benefit human health and drug development. Centered within the Abdul Latif Jameel Clinic for Machine Learning in Health (J-Clinic), the program brings together the MIT School of Engineering and Takeda Pharmaceuticals, to combine knowledge and address challenges of mutual interest.    Following a competitive proposal process, nine inaugural research projects were selected. The program’s flagship research projects include principal investigators from departments and labs spanning the School of Engineering and the Institute. Research includes diagnosis of diseases, prediction of treatment response, development of novel biomarkers, process control and improvement, drug discovery, and clinical trial optimization. “We were truly impressed by the creativity and breadth of the proposals we received,” says Anantha P. Chandrakasan, dean of Continue reading MIT-Takeda program launches